Agilent Technologies (A) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Agilent Technologies (A) do?
Agilent Technologies Inc (A) is a U.S.-listed company in Healthcare (Diagnostics & Research). What it does: Produces chromatographs, mass spectrometers, and pathology equipment for research and clinical laboratories. Makes analytical instruments and diagnostic tools that laboratories use to identify chemical compounds and biological. It is worth $49.43B on the market and sold $7.37B over the last year.
- Market cap
- $49.43B
- P/E ratio
- 34.5×
- Annual sales
- $7.37B
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Brief updated
- Nov 09, 2026
Brands and businesses behind A
- Dako: Supplies antibodies, reagents, and automated tissue-staining instruments to hospital labs for cancer diagnosis.
- BioTek: Builds microplate readers, washers, and imaging systems used in cellular analysis and pharmaceutical screening.
A’s flags, in plain English
Each flag is a number from Agilent Technologies’ reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 09, 2026.
Stupid Cash
Can pay this year's bills 2.1 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Low debt
Low debt, only 54% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.
Fat Margins
Profit margin of 19.5%. The company keeps a healthy share of each sale as profit, which gives it room when costs jump.
Priced for Perfection
Priced at 34.5 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.
2 more green flags open with the free trial. Try it free for 7 days.
Questions about A
How big is Agilent Technologies?
Agilent Technologies’ market cap is $49.43B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $7.37B: what customers paid the company over the last year, before any costs.
What is A’s P/E ratio?
A’s P/E ratio is 34.5×. Investors pay about 34.5 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with A?
Reduced research budgets across biotech and pharmaceutical companies directly depress demand for new lab equipment. That is one risk on Agilent Technologies’ card. Its first risk flag is Priced for Perfection, explained above. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Agilent Technologies’ own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. A’s filings on SEC.gov. The Margin Monkey is research, not advice.
